We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TD icon
301
Toronto Dominion Bank
TD
$198B
$8.07M 0.06%
142,913
+16,533
+13% +$838K
HPQ icon
302
HP
HPQ
$24.6B
$8.05M 0.06%
327,468
-48,280
-13% -$1.01M
STRO icon
303
Sutro Biopharma
STRO
$411M
$7.99M 0.06%
+36,811
New +$6.09M
MOR
304
DELISTED
MorphoSys AG American Depositary Shares
MOR
$7.98M 0.06%
281,486
-22,196
-7% -$608K
SYK icon
305
Stryker
SYK
$133B
$7.95M 0.06%
32,432
-11,407
-26% -$2.58M
ORA icon
306
Ormat Technologies
ORA
$5.94B
$7.94M 0.06%
87,897
-2,037
-2% -$154K
FIS icon
307
Fidelity National Information Services
FIS
$23.8B
$7.88M 0.06%
55,670
+2,841
+5% +$405K
GEN icon
308
Gen Digital
GEN
$16.3B
$7.87M 0.06%
378,597
+63,273
+20% +$1.28M
CYTK icon
309
Cytokinetics
CYTK
$10.9B
$7.81M 0.06%
375,853
+235,628
+168% +$4.31M
AERI
310
DELISTED
Aerie Pharmaceuticals
AERI
$7.79M 0.06%
576,495
-15,305
-3% -$185K
PSNL icon
311
Personalis
PSNL
$1.31B
$7.74M 0.06%
211,331
-296,274
-58% -$8.96M
TRI icon
312
Thomson Reuters
TRI
$43.1B
$7.72M 0.06%
89,656
+54,945
+158% +$4.71M
CMG icon
313
Chipotle Mexican Grill
CMG
$49.4B
$7.56M 0.06%
272,450
+18,950
+7% +$497K
ENTA icon
314
Enanta Pharmaceuticals
ENTA
$378M
$7.53M 0.06%
178,941
+114,907
+179% +$5.06M
LNG icon
315
Cheniere Energy
LNG
$54.1B
$7.53M 0.06%
125,347
+4,782
+4% +$256K
ROP icon
316
Roper Technologies
ROP
$38.5B
$7.35M 0.06%
17,058
+3,435
+25% +$1.41M
TU icon
317
Telus
TU
$16.8B
$7.32M 0.06%
369,843
+93,777
+34% +$1.77M
RY icon
318
Royal Bank of Canada
RY
$292B
$7.24M 0.06%
88,150
+10,562
+14% +$817K
SBAC icon
319
SBA Communications
SBAC
$19.3B
$7.17M 0.06%
25,421
+12,352
+95% +$3.63M
BNTX icon
320
BioNTech
BNTX
$23.5B
$7.15M 0.06%
87,761
-259,776
-75% -$25.5M
KEY icon
321
KeyCorp
KEY
$24.2B
$7.13M 0.06%
434,278
+219,768
+102% +$3.2M
CPB icon
322
Campbell Soup
CPB
$6.58B
$7.09M 0.06%
146,723
-168,913
-54% -$8.16M
RCKT icon
323
Rocket Pharmaceuticals
RCKT
$351M
$7.06M 0.06%
+128,749
New +$4.69M
WST icon
324
West Pharmaceutical
WST
$23.9B
$6.97M 0.06%
24,620
-1,037
-4% -$291K
FRC
325
DELISTED
First Republic Bank
FRC
$6.97M 0.06%
47,407
-15,893
-25% -$2.07M

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.